Scientific Reference

KPV (Lys-Pro-Val)

Evidence profile: Predominantly preclinical

KPV (Lys-Pro-Val) is a tripeptide derived from the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). Unlike the parent hormone, KPV retains potent anti-inflammatory and immunomodulatory activity without inducing melanogenesis or pigmentation. It has been investigated for its ability to modulate inflammatory pathways at the cellular level, with particular relevance to inflammatory bowel disease, dermatological conditions, and systemic inflammation. Its small size enables efficient cellular penetration and direct interaction with intracellular signaling pathways.